$JAZZ Company News Speculators live by the sword, die

New Post Public Reply Private Reply Replies (0) Message Board

Aug 17, 2014 at 12:18 PM

$JAZZ Company News

Speculators live by the sword, die by the sword 3:13 p.m. July 8, 2014 - The Trading Deck
Two reasons a top is not yet imminent 2:12 p.m. July 3, 2014 - The Trading Deck
Apple and Beats,Tesla and Missouri car dealers, plus the missing momo 8:36 a.m. May 9, 2014 - Barbara Kollmeyer
Jazz Pharmaceuticals swings to first-quarter loss 10:53 p.m. May 8, 2014 - MarketWatch.com
Dow industrials hesitate at major resistance 11:23 a.m. April 23, 2014 - Michael Ashbaugh
The case for the bears weakens 2:55 p.m. Feb. 25, 2014 - The Trading Deck
A stock that protects your identity and your portfolio 12:56 p.m. Feb. 3, 2014 - The Trading Deck
13 stocks set to outperform in 2014 from Sabrient's David Brown 8:21 p.m. Jan. 14, 2014 - blogs.marketwatch.com
Sex bot on Volcker, dream gigs at Twitter and Wall Street's whiffs 9:27 a.m. Dec. 11, 2013 - Shawn Langlois
Dow industrials vie for all-time closing high 12:09 p.m. Nov. 21, 2013 - Michael Ashbaugh
One biotech that shouldn’t be missed 10:26 a.m. June 5, 2013 - The Trading Deck
Charting the S&P’s test of record territory 11:57 a.m. March 12, 2013 - Michael Ashbaugh
Charting the S&P’s test of record territory 11:51 a.m. March 12, 2013 - Michael Ashbaugh
S&P 500 nears next technical test 12:07 p.m. Nov. 30, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 12:11 p.m. Oct. 2, 2012 - Michael Ashbaugh
Charting the fourth-quarter start 11:50 a.m. Oct. 2, 2012 - Michael Ashbaugh
4 stocks with charts pointing higher 6:58 a.m. Oct. 2, 2012 - The Trading Deck
Dow, Nasdaq hesitate at the range top 11:22 a.m. Sept. 24, 2012 - Michael Ashbaugh
Jazz Pharmaceuticals gains on Xyrem court ruling 12:15 p.m. Sept. 17, 2012 - Val Brickates Kennedy
Meda buys women's-health portfolio in US for $95M 2:56 a.m. Sept. 6, 2012 - MarketWatch.com

Jazz Pharmaceuticals Is Taking Two Routes To Growth 5:10 p.m. Aug. 15, 2014 - Investors Business Daily
3 Health Care Stocks Pushing The Sector Higher 1:03 p.m. Aug. 15, 2014 - TheStreet.com
Insider Trading Alert - JAZZ, ATRO And RHI Traded By Insiders 11:45 a.m. Aug. 15, 2014 - TheStreet.com
Jazz Pharmaceuticals (JAZZ) Is Today's Momo Momentum Stock 9:51 a.m. Aug. 15, 2014 - TheStreet.com
Stock Market News for August 14, 2014 - Market News 10:10 a.m. Aug. 14, 2014 - Zacks.com
Jazz Pharmaceuticals (JAZZ) in Focus: Stock Surges 8.8% - Tale of the Tape 8:44 a.m. Aug. 14, 2014 - Zacks.com
Watch Out: Barbarians At The Gate For Jazz Pharmaceuticals (JAZZ) 3:55 p.m. Aug. 13, 2014 - TheStreet.com
Jazz Pharmaceuticals PLC Stock Upgraded (JAZZ) 11:12 a.m. Aug. 13, 2014 - TheStreet.com
Why Jazz Pharmaceuticals (JAZZ) Could Be an Impressive Growth Stock - Tale of the Tape 8:44 a.m. Aug. 12, 2014 - Zacks.com
3 Stocks Dragging The Health Care Sector Downward 1:04 p.m. Aug. 11, 2014 - TheStreet.com
12 Top Consensus Stock Holdings From Best 3 Health Care Active Mutual Funds 10:54 a.m. Aug. 10, 2014 - Seeking Alpha
Perilous Reversal Stock: Jazz Pharmaceuticals (JAZZ) 2:51 p.m. Aug. 7, 2014 - TheStreet.com
Jazz Pharmaceuticals (JAZZ) Jumps: Stock Moves 5.2% Higher - Tale of the Tape 9:46 a.m. Aug. 7, 2014 - Zacks.com
Jazz Pharmaceuticals Public Limited Company (JAZZ): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 8:00 a.m. Aug. 7, 2014 - Zacks.com
Jazz Pharma Jumps After Q2 Earnings Rebound 12:36 p.m. Aug. 6, 2014 - Investors Business Daily
Barbarian At The Gate: Jazz Pharmaceuticals (JAZZ) 10:13 a.m. Aug. 6, 2014 - TheStreet.com
Earnings Up at Jazz Pharmaceuticals, Revenue Guidance Raised - Analyst Blog 9:30 a.m. Aug. 6, 2014 - Zacks.com
Jazz Pharmaceuticals Spikes In #PreMarket On Q2 Beat; Boosts Revenue Outlook 8:33 a.m. Aug. 6, 2014 - benzinga.com
Jazz Pharmaceuticals' (JAZZ) CEO Bruce Cozadd on Q2 2014 Results - Earnings Call Transcript 11:58 p.m. Aug. 5, 2014 - Seeking Alpha
4 Top-Rated Drugmakers Beat Q2 Earnings Estimates 5:30 p.m. Aug. 5, 2014 - Investors Business Daily

Critical Alerts For Kate Spade & Co, Canadian Solar, Jazz Pharmaceuticals, InterMune and Micron. Released By InvestorsObserver 9:31 a.m. Aug. 14, 2014 - PR Newswire - PRF
Product Launch, Technical Updates, Clinical Study Results, Completion of Tender Offer, and Financial Result - Research Reports on Medtronic, Covidien, Johnson & Johnson, Merck and Jazz 9:20 a.m. Aug. 11, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes 6:30 a.m. Aug. 8, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes 4:05 p.m. Aug. 6, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Second Quarter 2014 Financial Results And Updated Guidance 4:05 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Completes Acquisition Of Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. 4:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Participation at Canaccord Genuity Conference on August 13 4:10 p.m. Aug. 4, 2014 - PR Newswire - PRF
Financial Results, Clinical Trial Initiations, Drug Designations, Appointments, and Study Results - Research Reports on Cubist, Jazz, InterMune, NPS Pharmaceuticals and ACADIA 9:00 a.m. July 30, 2014 - PR Newswire - PRF
Biotech Companies Release Quarterly Financials and Announce Earnings Release Dates - Research Reports on Illumina, Alexion, Questcor, Jazz Pharmaceuticals and Exelixis 8:40 a.m. July 29, 2014 - PR Newswire - PRF
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commercialize Caphosol® in China 11:34 a.m. July 28, 2014 - BusinessWire - BZX
CANbridge Life Sciences And EUSA Pharma Form Agreement to Commericalize Caphosol® in China 8:02 a.m. July 28, 2014 - BusinessWire - BZX
Equities to Watch in the Health Care Sector -- ImmunoCellular Therapeutics, Aeterna Zentaris, Lexicon Pharma, BioDelivery Sciences Intl., and Jazz Pharma 8:40 a.m. July 23, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals to Report 2014 Second Quarter Financial Results on August 5, 2014 4:05 p.m. July 22, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals and Concert Pharmaceuticals Provide a Phase 1 Clinical Trial Update on JZP-386 4:05 p.m. July 21, 2014 - BusinessWire - BZX
Critical Alerts For GoPro, Canadian Solar, Questcor Pharmaceuticals, Caesars Entertainment, and Jazz Pharmaceuticals Released By InvestorsObserver 9:31 a.m. July 8, 2014 - PR Newswire - PRF
Agreements, NDA Submissions, FDA Approvals, Enrollment Updates, and Index Inclusions - Analyst Notes on Jazz Pharmaceuticals, Vertex, NPS, StemCells and Achillion 5:50 a.m. July 7, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc. 8:00 a.m. July 2, 2014 - PR Newswire - PRF
Pharmaceuticals Stocks Technical Momentum -- Research on Jazz Pharma, Omeros, Pernix Therapeutics Holdings, and Salix Pharma 7:10 a.m. June 16, 2014 - PR Newswire - PRF
Jazz Pharmaceuticals Presents JZP-110 Phase 2b Data For The Treatment Of EDS Symptoms In Adults With Narcolepsy 2:40 p.m. June 2, 2014 - PR Newswire - PRF
Appointment, Investor Conferences, and Expanded Healthcare Services - Analyst Notes on Jazz Pharmaceuticals, Zoetis, Community Health Systems, Tenet and Stryker 5:00 a.m. May 28, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endava Facing Securities Fraud Suit; Stocks Down 24%

Endava Hits Rough Patch with Legal Battle Brewing So here we are, watching Endava plc struggle through legal quagmires and tumbling stock prices. Come September 21, 2026, news hit the street: Endava's CFO, Mark Thurston, found himself on administrative leave due to an investigation surrounding some shaky accounting practices. The Audit Committee raised a red flag, and...

JobPlanner Boosts Tools to Shield Margins in Construction

Real-Time Solutions for Real-World Challenges JobPlanner is stepping up its game with some beefed-up financial management tools, and I gotta admit, it's like a lifeline in the raging sea of construction costs. We're talking about a souped-up Real-Time Job Costing Suite tailored for general and specialty contractors who are tired of watching their profits evaporate into...

Chicken Salad Chick Spices Up Holidays With Mary Mistletoe

Dishing Out Holiday Spirit by the Scoop The holiday season's rolling around, and Chicken Salad Chick, this fast-casual joint that's got a bit of a thing for chicken salad, isn't letting the festive season pass by without a splash. They've brought out Mary Mistletoe, a holiday-themed chicken salad offering that just might become your table's centerpiece. "We wanted Mary...

Martin's Holiday Heatwave: Mixing Summer Flavors

Holiday Heatwave Meets Winter Cheer with Martin's Rolls Hold onto your oven mitts, folks, because Martin’s Famous Potato Rolls and Bread is stirring up the winter doldrums with an unexpected twist this holiday season. Forget the old cranberry sauce routine—it’s all about mixing sunny vibes with frosty festivities in their "Very Merry Martin’s: Holiday Heatwave."...

Atrium's Heart Therapies: ATR 1072's Promising Data

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

Target Hospitality Readies for Q3 2026 Earnings Reveal

The Thrill of Earnings Season Every trader worth their salt gets a tingle down the spine come earnings season. There's nothing quite like it—the build-up, the anticipation, the potential payouts. This time, we're zeroing in on Target Hospitality, bearing the ticker NASDAQ: TH. Come November 9, 2026, they're set to unveil what the past quarter had up its sleeve, and like...

New Paths Emerge in Thin Film Dewetting Control

The Thin Film Challenge: Decoding Dewetting Ah, dewetting—it's a bit like trying to keep a chocolate bar solid on a scorching summer day. These thin films, they're supposed to hold their own, spread thin and steady. But apply a little heat or a laser, and watch them form tiny islands, like a retreating tide. Now, there's some fresh thinking in the air, straight from...

FirstEnergy Foundation Aims High with New Leadership

Changing the Guard at FirstEnergy Foundation For a company with a hefty footprint across the northeastern United States, FirstEnergy Corp. (NYSE: FE) seems to be diving deep into the philanthropic pool with its recent leadership shuffle. Don Rettig, an experienced figure in the world of corporate philanthropy, is taking the helm as Vice President and President of the...

Ebix and intentyx Tackle AI Security in Regulated Fields

Ebix Aims to Rein in AI Mischief When you throw AI agents into the mix of regulated businesses like insurers, banks, and healthcare outfits, you get a storm brewing. Now, Ebix and intentyx seem to be donning their capes, aiming to bring clarity with their new SMARE security platform. Fancy name notwithstanding, this isn't about mind games—it's about real, observable...

Harel Insurance Preps Q3 2026 Earnings Report

Harel's Financial Spotlight: Next Moves on November 23, 2026 Harel Insurance Investments, a bigwig in the Israeli insurance landscape, is about to pull back the curtain on its third quarter 2026 financial report. Come November 23, the numbers will hit the streets, and every investor's gotta be asking: what's the latest play from Harel? Exploring Harel's Strategic...